Impact of elective cesarean sections on newborn respiratory distress

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study examines the relationship between elective cesarean sections and the incidence of respiratory distress syndrome in newborns. It focuses on pregnant women aged 20-39 years with singleton pregnancies at or beyond 37 weeks of gestation who have received corticosteroids to enhance lung maturity. The study utilizes Doppler velocimetry, a non-invasive ultrasound method, to assess fetal pulmonary circulation and predict respiratory outcomes. The goal is to better understand the risks associated with elective cesarean deliveries in term pregnancies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Maternal age of 20-39 years.
2. Women with singleton pregnancy ≥ 37 weeks
3. Pregnant women who received corticosteroid to enhance lung maturity and will be subjected to elective cesarian section (before onset of labour) within 1 week after administration of corticosteroid

Exclusion Criteria:

1. Women with oligohydramnios or polyhydramnios.
2. Women with underlying disease requiring corticosteroids.
3. Pregnant women with any medical disorders such as hypertension, diabetes, renal diseases, antiphospholipid syndrome, intrauterine growth restriction, preterm premature rupture of membrane, placenta previa, antepartum haemorrhage, on anticoagulant thereby.
4. Women with confirmed fetal malformation.
5. Women who will refuse to participate.

Where it's running

• Woman's Health Hospital - Assiut university
  Asyut, Egypt Recruiting

Study contacts

• Study coordinator: Mohammed K Ali, MD
• Email: m_khairy2001@yahoo.com
• Phone: 01005537951

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Caffeine in pregnancy: how the mother and baby handle it during delivery

  This study tests how caffeine is processed in pregnant people and how much reaches the baby when given shortly before delivery.

  Recruiting Phase 1 Indiana University · Indianapolis, Indiana · NCT07570121

• L-carnitine for preterm babies with respiratory distress syndrome

  This will see if giving L-carnitine to preterm babies with respiratory distress helps them gain weight, leave the hospital sooner, or survive the early newborn period.

  Recruiting RESnTEC, Institute of Research · Muzaffargarh, Punjab Province · NCT07437391

• Serum endocan and copeptin levels in preterm babies with respiratory distress

  This will test whether blood levels of endocan and copeptin on the first day of life are linked to how severe respiratory distress is in preterm newborns (28–36 weeks).

  Recruiting Tanta University · Tanta, El-Gharbia · NCT07154134

• Lung and heart ultrasound for acute breathlessness in older adults

  This project will test whether using bedside lung and heart ultrasound helps doctors quickly find the cause and give the right treatment for sudden breathlessness in people over 65.

  Recruiting University Hospital, Toulouse · Toulouse · NCT06807983

• APC-0101 with noninvasive breathing support for preterm infants with respiratory distress syndrome

  This will test whether inhaled APC-0101 given with nCPAP/NIV helps preterm infants with respiratory distress syndrome breathe better than nCPAP/NIV alone.

  Recruiting at 30 sites Phase 3 Aerogen Pharma Limited · Little Rock, Arkansas and 30 other locations · NCT06776783

• Evaluating a new treatment to prevent severe COVID-19 complications

  This study is testing a new treatment to see if it can help hospitalized COVID-19 patients avoid severe complications caused by inflammation.

  Recruiting at 3 sites Phase 1/2 Peaches Biotech · Alcalá de Henares, Madrid and 2 other locations · NCT06684379

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.